Dr. Chirag Shah is a radiation oncologist and director of clinical research for the department of radiation oncology at the Cleveland Clinic. Dr. Shah received his bachelor's degree from Youngstown State University and his medical degree from Northeast Ohio Medical University. He completed his internship and residency at William Beaumont Hospital from 2007 to 2012 and joined the Cleveland Clinic Staff in 2015. Dr. Shah serves as a reviewer for various medical journals and is a member of various medical societies. His primary research interests are breast cancer, sarcoma, prostate cancer, lymphoma, and innovative radiation treatment schedules as well as lymphedema. He has participated in numerous clinical trials. In this podcast, Dr. Shah talks about specific characteristics of early-stage breast cancer that make the cancer more likely to come back, which doctors call recurrence. Listen to the podcast to hear Dr. Shah discuss: the difference between local/regional recurrence and metastatic/distant recurrence the characteristics of early-stage breast cancer that make the risk of recurrence higher Editor’s Note: Please know that Dr. Shah does point out that more research is needed on how diet, alcohol use, and smoking affect recurrence risk because current data are inconsistent. His ultimate point is that a survivorship care plan, which includes monitoring, is the most important tool we have beyond following your treatment plan to reduce the risk of recurrence. A survivorship care plan includes: monitoring for and managing long-term physical and emotional side effects guidance about diet, exercise, and health-promoting activities resources to help with financial and insurance issues surveillance

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related